J Rheum Dis.  2015 Dec;22(6):335-336. 10.4078/jrd.2015.22.6.335.

The Incidence of Uveitis in Ankylosing Spondylitis Patients Undergoing Tumor Necrosis Factor Inhibiting Therapy in Korea

• Choi SJ

• KMID: 2222806
• DOI: http://doi.org/10.4078/jrd.2015.22.6.335

Abstract

No abstract available.

MeSH Terms

Humans
Incidence*
Korea*
Spondylitis, Ankylosing*
Tumor Necrosis Factor-alpha*
Uveitis*
Tumor Necrosis Factor-alpha

Reference

1. Max R, Lorenz HM, Mackensen F. Ocular involvement in spondyloarthropathies: HLA B27 associated uveitis. Z Rheumatol. 2010; 69:397–402.

2. Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74:65–73.

3. Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008; 67:955–9.

4. Rudwaleit M, Rødevand E, Holck P, Vanhoof J, Kron M, Kary S, et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis. 2009; 68:696–701.

5. Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M, et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis. 2006; 65:1631–4.

6. Wendling D, Paccou J, Berthelot JM, Flipo RM, Guillaume-Czitrom S, Prati C, et al. CRI. New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin Arthritis Rheum. 2011; 41:503–10.

7. Kim HS, Kim TJ, Bae SC, Yoo DH, Jun JB, Kim TH. TNF Inhibitors and uveitis in ankylosing spondylitis. J Korean Rheum Assoc. 2009; 16:48–53.

8. Koo BS, Hong S, Kim YJ, Lee CK, Yoo B, Kim YG. The incidence of uveitis in ankylosing spondylitis patients undergoing tumor necrosis factor inhibiting therapy in Korea. J Rheum Dis. 2015; 22:288–92.